Author:
Pinto Lana C.,Falcetta Mariana R.,Rados Dimitris V.,Leitão Cristiane B.,Gross Jorge L.
Funder
Ministry of Science, Technology and Innovation | Conselho Nacional de Desenvolvimento Científico e Tecnológico
Publisher
Springer Science and Business Media LLC
Reference25 articles.
1. Drucker, D. J. The biology of incretin hormones. Cell Metab 3, 153–165,
https://doi.org/10.1016/j.cmet.2006.01.004
(2006).
2. Perfetti, R., Zhou, J., Doyle, M. E. & Egan, J. M. Glucagon-like peptide-1 induces cell proliferation and pancreatic-duodenum homeobox-1 expression and increases endocrine cell mass in the pancreas of old, glucose-intolerant rats. Endocrinology 141, 4600–4605,
https://doi.org/10.1210/endo.141.12.7806
(2000).
3. Matveyenko, A. V. et al. Beneficial endocrine but adverse exocrine effects of sitagliptin in the human islet amyloid polypeptide transgenic rat model of type 2 diabetes: interactions with metformin. Diabetes 58, 1604–1615,
https://doi.org/10.2337/db09-0058
(2009).
4. Elashoff, M., Matveyenko, A. V., Gier, B., Elashoff, R. & Butler, P. C. Pancreatitis, pancreatic, and thyroid cancer with glucagon-like peptide-1-based therapies. Gastroenterology 141, 150–156,
https://doi.org/10.1053/j.gastro.2011.02.018
(2011).
5. Administration, F. a. D. FDA Drug Safety Communication: FDA investigating reports of possible increased risk of pancreatitis and pre-cancerous findings of the pancreas from incretin mimetic drugs for type 2 diabetes,
https://www.fda.gov/Drugs/DrugSafety/ucm343187.htm
(2016).
Cited by
46 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献